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White cell countBackground: Spontaneous Stone Passage (SSP) rates in acute ureteric colic range from 47 to 75%. There is
conflicting evidence on the role of raised inflammatory markers in acute ureteric colic. The use of an
easily applicable biomarker that could predict SSP or need for intervention would improve the manage-
ment of obstructing ureteric stones. Thus, there is a need to determine in an appropriately powered
study, in patients who are initially managed conservatively, which factors at the time of acute admission
can predict subsequent patient outcome such as SSP and the need for intervention. Particularly, establish-
ing whether levels of white cell count (WBC) at presentation are associated with likelihood of SSP or
intervention may guide clinicians on the management of these patients’ stones.
Design: Multi-center cohort study disseminated via the UK British Urology Researchers in Surgical
Training (BURST) and Australian Young Urology Researchers Organisation (YURO).
Primary research question: What is the association between WBC and SSP in patients discharged from
emergency department after initial conservative management?
Patient population: Patients who have presented with acute renal colic with CT KUB evidence of a solitary
ureteric stone. A minimum sample size of 720 patients across 15 centres will be needed.
Hypothesis: A raised WBC is associated with decreased odds of spontaneous stone passage.
Primary outcome: The occurrence of SSP within six months of presentation with acute ureteric colic (YES/
NO). SSP was defined as absence of need for intervention to assist stone passage.
Statistical analysis plan: A multivariable logistic regression model will be constructed, where the outcome
of interest is SSP using data from patients who do not undergo intervention at presentation. A random
effect will be used to account for clustering of patients within hospitals/institutions. The model will
include adjustments for gender, age as control variables.
 2017 The Authors. Published by Elsevier Ltd on behalf of Surgical Associates Ltd. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction/background
Urolithiasis is a very common problemwith a lifetime incidence
of up to 19% in men and 8% in women. In a high-income European
Country, studies report over 750,000 cases a year with 25%
experiencing recurrence [1–3]. The American Urology Association
and European Association of Urology guidelines report a 68%spontaneous ureteral stone passage rate for stones <5 mm and
47% for stones between 5 and 10 mm [4]. Median time to stone
passage was 39–40 days for stones less than 10 mm. In patients
who do not have immediate intervention on presentation, there
is uncertainty as to when intervention is necessary, if at all. The
use of an easily applicable biomarker that could predict sponta-
neous stone passage or need for intervention would improve the
management of obstructing ureteric stones.
There is conflicting evidence on the role of raised inflammatory
markers in acute ureteric colic with some studies showing raised
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sage rate whilst others claiming a lower rate with an increased
need for intervention. After a multivariable analysis, Sfoungaristos
found a statistically significant increased chance of stone passage
in patients with a raised WBC or neutrophil count [5]. They rea-
soned that as both WBC and neutrophils are general markers of
inflammation they could represent the inflammation caused to
the ureter by the stone passage and suggested that stones that
do pass along the length of the ureter may have greater potential
to cause inflammation.
However, Park et al., showed directly conflicting results, where
the stone passage rate was 11.4% higher in those with a normal
neutrophil count when compared to those with a raised count,
defined as >74% [6]. The authors also found a decreased sponta-
neous stone passage rate with increasing CRP levels (high group
defined as >10 mg/dl). They reasoned that the inflammatory
response leads to oedema and ureteric convulsion which prevent
spontaneous stone passage. Others have also found a negative cor-
relation with raised CRP and spontaneous stone passage and
Angulo et al. found an increased need for intervention in those
with a raised WBC and/or CRP [7,8].
Given the conflicting evidence, there is a need to determine in
an appropriately powered study, in patients who are initially man-
aged conservatively, which factors at the time of acute admission
can predict subsequent patient outcome such as spontaneous
stone passage and the need for intervention. Particularly, establish-
ing whether levels of white cell count at presentation are associ-
ated with likelihood of spontaneous passage or intervention may
guide clinicians on the management of these patients’ stones. This
study will also allow us to determine regional variations in stone
management, highlighting areas for guideline development.
The study was designed to allow reporting according to the
STROBE guidelines (The Strengthening the Reporting of Observa-
tional Studies in Epidemiology (STROBE) statement: guidelines
for reporting observational studies) [9].
2. Methods and analysis
2.1. Design
Multi-center cohort study disseminated via the UK British Urol-
ogy Researchers in Surgical Training (BURST) and Australian Young
Urology Researchers Organisation (YURO).
Emergency department records, follow up records and surgical
entry notes will be assessed retrospectively for all consecutive
patients at the site who met the eligibility criteria (See Section 2.4).
Patients are followed up for 6 months or until they experience
spontaneous stone passage or intervention. Follow-up data is
defined as verifiable information on patient attendance to either
an outpatient clinic, imaging test or admission for intervention.
Phase 1: A pilot study in 120 patients at 6 sites (20 per site).
This phase has been completed.
Pilot outcome measures included 1. Ease of subject selection, 2.
Availability of data, 3. Ease of use of data collection tool, 4. Suitabil-
ity of variables selected and 5. Time taken per patient.
The pilot study revealed adequate data on selected variables
was routinely recorded retrospectively. The data collection tool
was refined for use in the main phase of the study.
Phase 2: Multi-centre study in at least 720 patients in at least
15 sites.
2.2. Primary research question
What is the association between White Cell Count (WBC) and
spontaneous stone passage (SSP) in patients discharged from
emergency department after initial conservative management?SSP was defined as absence of need for intervention to assist
stone passage, in line with landmark studies in this field [10].
2.3. Secondary research questions
I. What is the association between CRP and SSP in patients
presenting with acute ureteric colic?
II. What is theWCC and CRP threshold associated with the low-
est SSP rate?
III. What is association between medically expulsive use (MET)
and SSP?
IV. What are the strongest predictors of spontaneous stone pas-
sage in patients with acute ureteric colic when adjusting for
key confounding variables?
V. Is there regional variation in the management of patients
presenting with acute ureteric colic?
2.4. Patient population
Patients who have presented with acute renal colic who have CT
KUB evidence of a solitary ureteric stone.
Exclusion criteria include: patients with non-obstructing renal
stones, patients with multiple ureteric stones and patients who
have second or subsequent presentation of a previous stone.
2.5. Hypothesis
A raised WCC is associated with decreased odds of spontaneous
stone passage.
2.6. Follow up
Patients will be followed up for at least 6 months or until they
experience spontaneous stone passage or intervention.
2.7. Power calculation
Outcome variable defined as:
1 = Stone-free
0 = Not stone free
As per the accepted criteria of 10 events per variable (EPV) set
up by Peduzzi et al. for logistic regression analyses and making that
assumption that 0.25 is the rate of the ‘‘rarer event” (25% not stone
free – amongst those who were discharge with conservative man-
agement) our sample size was deemed as being:
 m = number of model parameters for explanatory variable
effects.
 r = estimated overall rate of intervention/non-passage of
stone. Then, approximately, the total number of patients required
is given by:
N = (10 m)/r = (10  18)/0.25 = 720 patients
Thus, a sample size of 720 patients will be sufficient.3. Statistical analysis plan
Analysis will follow a pre-specified statistical analysis plan,
with no planned interim analyses.
3.1. Organisation of data
Release of collected data shall occur after the final participant
has completed follow-up, once all data have been entered onto
the database and checked and the SAP has been finalised and
approved
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on the collected data on a site-by-site basis, by a member of the
MIMIC Study Group independent to that site. To ensure high qual-
ity data, each primary and secondary outcome variable will be
checked for:
 missing values;
 values beyond an acceptable range;
 consistency between different variables;
 date consistencies
 other inconsistencies.
In addition, 10% of all patient data for each site will be checked
at random for sense and consistency. The findings of data quality
assessment will be documented with full audit record.
If missing values or other inconsistencies are present, then
queries will be sent to the site to address.3.2. Summary of outcome measures
Variables of interest will be summarised at presentation. The
term ‘presentation’ refers to a patient’s entry to the cohort, in other
words, the visit at which he/she first presents with acute ureteric
colic and is eligible to enter the cohort.
We shall provide statistical summaries for the following vari-
ables at presentation:
a) Hospital/Institution site
b) Year of presentation
c) Age (in years)
d) Gender (male/female)
e) Previous stone history (YES/NO)
f) Stone size (in mm)⁄
g) Stone side (right or left)⁄
h) Stone location (proximal ureter, mid ureter, distal ureter)⁄
i) White blood cell count (WBC) (in  109/L)
j) Neutrophil count (in  109/L)
k) C-Reactive protein (CRP) level (in mg/L)
l) Creatinine (umol/L)
m) Hydronephrosis (YES/NO)⁄
n) Hydroureter (YES/NO)⁄
o) Peri-nephric stranding (YES/NO)⁄
p) Administration of NSAID (YES/NO)
q) Administration of Medically Expulsive Therapy (MET)
(YES/NO)
r) Administration of antibiotics (YES/NO)
⁄As reported by the radiologist
3.3. Primary outcome
The occurrence of ‘spontaneous stone passage’ within six
months of presentation with acute ureteric colic (YES/NO). Sponta-
neous stone passage (SSP) was defined as absence of need for inter-
vention to assist stone passage.
3.4. Secondary outcomes
 Mean white cell count (in  109/L)
 Mean C-reactive protein (mg/L)
 Proportion of patients who have immediate intervention
 Proportion of patients who have subsequent intervention dur-
ing follow up
 Proportion of patients who have ureteroscopy/cystoscopy and JJ
stenting/nephrostomy Proportion of patients who are lost to follow up after initial
presentation
 Mean stone size (mm)
 Proportion of patients with upper/mid/distal ureteric stones
 Proportion of patients having medical expulsive therapy
 Proportion of patents having antibiotics
 Proportion of patients having NSAIDs
 Proportion of patients with renal impairment
3.5. Statistical analyses
3.5.1. Description of demographic variables at presentation
Continuous variables will be summarised by reporting the
mean, standard deviation and range. Categorical variables will be
summarised using frequency tables.
Summaries will be shown for all patients and stratified by
whether or not a patient underwent an intervention at presenta-
tion (i.e. before discharge).
3.5.2. Loss to follow-up
A descriptive summary of patients lost to follow-up shall be
made.
For patients lost to follow-up we all participating centers will be
advised to make adequate arrangements to contact patients. From
the pilot, it was found that this was dependent on the local infras-
tructure but often involved a telephone calls and/or letters to
patients/GP.
3.5.3. Primary outcome analyses
Immediately after presentation, patients shall be classified as
either having (1) undergone intervention at presentation (i.e.
before discharge) or (2) discharged shortly after presentation with
no further intervention at that point. The number of patients who
undergo intervention at presentation shall be reported.
The group of patients for whom the primary outcome is of most
interest is those who are discharged after presentation without, at
that time, any intervention. For this group:
A multivariable logistic regression model will be constructed,
where the outcome of interest is ‘spontaneous stone passage
within six months’ using data from patients who do not undergo
intervention at presentation. A random effect will be used to
account for clustering of patients within hospitals/institutions.
The multivariable model will include adjustments for gender, age
as control variables.
Univariable logistic regression models will be used to deter-
mine the level of association between other variables of interest
(reported in Section 3.2) and spontaneous stone passage within
six months. Variables for which there is a significant association
with spontaneous stone passage in the corresponding fitted uni-
variable model will be included in final multivariable model for
spontaneous stone passage. A significant association is determined
by a P-value < 0.05 in a hypothesis test pertaining to the corre-
sponding model coefficient, after accounting for multiple hypothe-
sis testing using a Bonferroni correction).
Through fitting this model, the main aim is to a make inference
on the variables that influence the probability of ‘spontaneous
stone passage’ within six months of presentation. Odds ratios,
related to the probability of spontaneous stone passage, shall be
reported for each explanatory variable. The predictive ability of
the final model shall be assessed using ten-fold cross-validation.
3.5.4. Secondary outcome analyses
Continuous secondary outcome variables will be modelled
using mixed effects liner models (with transformations of variables
performed, where appropriate). Binary secondary outcome
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models.
3.5.5. Other exploratory analyses
 Consideration will be given to a time to event analysis investi-
gating the association of white cell count and spontaneous
stone passage from initial presentation with acute renal colic
to spontaneous stone passage.
 Further Cox and logistic regression models that include other
variables measured at presentation (e.g. stone size, neutrophil
count) shall be considered, as both univariable models and for
inclusion in multivariable models.
 A range of investigatory inflammatory markers will be recorded
at baseline and their role in acute renal colic and spontaneous
stone passage may be explored in subsequent studies.
3.5.6. Missing data
An adjustment for missing explanatory variables will be consid-
ered in the analysis of the primary outcome only. Baseline charac-
teristics of patients with and without missing values will be
compared. Depending on the extent of missingness, the predictors
of missing values will be identified the primary outcome analysis
will be adjusted for those predictors of missing values which are
related to missingness. A sensitivity analysis of the primary out-
come that accounts for missing data shall be considered using mul-
tiple imputation (11).
4. Ethics
All local institutional governance processes will be followed
prior to carrying out the project at that site. Where ethical approval
is required this shall be obtained. Where research and develop-
ment departments grant ethical exemption for this service evalua-
tion project, registration numbers, when granted, will be kept
centrally.
5. Discussion
Urolithiasis is a common problem that is currently on the rise in
the some developed countries [11]. During the acute admission
there is some consensus as to which patients warrant urgent
immediate intervention (e.g. those with sepsis). However it is less
clear how to manage the large cohort of patients who are initially
managed conservatively and do not require immediate interven-
tion. Specifically, quantifying the probability of spontaneous stone
passage and thus determining the need for intervention is chal-
lenging. A biomarker that could be measured on first presentation
that could predict spontaneous stone passage would help guide
management of these patients. Inflammatory markers, such as
white cell count, would be attractive biomarkers, though there is
conflicting evidence on the role of raised inflammatory markers
in acute ureteric colic and spontaneous stone passage, with previ-
ous studies also either lacking power and/or not adjusting for
important confounding factors.
MIMIC aims to show whether there is any association between
WBC on admission and spontaneous stone passage in patients fol-
lowed up for 6 months. Other potential confounders of SSP will be
adjusted for. These data will be used by to develop a risk calcula-
tor/model predicting spontaneous stone passage in patients pre-
senting with acute ureteric colic. Such a calculator would allow a
more informed decision making process with patients regarding
their management plans.
In addition, regional variation in the follow-up and manage-
ment of patients admitted with acute ureteric colic will bedetermined. There are also a group of patients who are deemed lost
to follow-up and they warrant further investigation as they are at
risk of potential chronic renal injury from a prolonged silently
obstructing stone. It will be assessed whether institutional proto-
cols are robust enough to ensure good follow up of these patients.
MIMIC aims to provide an evidence base that can guide clini-
cians in the management of patients with acute renal colic. MIMIC
data may lead to the design of interventional studies, which can be
used to improve the management of patients with acute renal
colic.
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